Status:
WITHDRAWN
Essential Amino Acid Supplementation in Older Adult COVID-19 Patients
Lead Sponsor:
University of Arkansas
Conditions:
Covid19
Eligibility:
All Genders
55+ years
Phase:
PHASE2
PHASE3
Brief Summary
A 4-week treatment of essential amino acids or placebo to participants with: 1) negative COVID-19 test with exposure, or 2) positive COVID-19 test and no or mild symptoms. The study team will measure ...
Detailed Description
In people who have been exposed to COVID-19 and have been tested (positive or negative) with no to mild symptoms, the study team will administer a treatment of essential amino acids (EAA). The study t...
Eligibility Criteria
Inclusion
- Exposure to COVID-19 in the last 60 days with no symptoms, with a COVID negative test Close contact: within 6 feet of a COVID-19 positive person for more than a few minutes without wearing PPE, or having direct contact with infectious secretions without PPE
- Positive COVID-19 test with or without symptoms
Exclusion
- COVID-19 positive hospitalized patient
- Patients who have symptoms of COVID but have not been tested.
- Unable to tolerate oral intake
- In hospice or palliative care
- Unstable medical or psychiatric condition
- Other criteria deemed acceptable by principle investigator
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04816071
Start Date
May 1 2021
End Date
May 1 2021
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205